- Key Architect of Foundation's Strategy Will Build On and Expand Transformational Approach -
NEW YORK, Dec. 14 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) today announced the appointment of Katie Hood as chief executive officer.
Ms. Hood, who joined the Foundation in September 2002, has been serving as interim CEO since October. As chief executive officer, she will build on the Foundation's strategy of inserting itself proactively into the research process to advance scientific breakthroughs, including the expansion of current initiatives to:
-- validate promising drug targets, thereby opening new opportunities for drug development;
-- increase investment in various stages of pre-clinical research and chaperoning pre-clinical hits from stage to stage;
-- selectively support clinical projects with the potential to improve patients' lives in the near-term; and
-- drive high-risk, high-reward attempts to uncover new research tools such as biomarkers.
Ms. Hood stated, "The Michael J. Fox Foundation has evolved into an organization willing to do whatever it takes to accelerate life-transforming treatments for Parkinson's patients - going beyond innovative funding mechanisms to work to change a flawed system that too often fails to translate research into results. Over the past seven years, we have built a unique expertise about Parkinson's research that we intend to leverage for impact over the coming months and years. Our capital should be -- and will be -- used to drive progress in ways that other funding sources are not."
David Golub, chairman of the Board of Directors of The Michael J. Fox
Foundation, said: "We are committed to a strategy of working relentlessly
to close critical gaps in the process of moving potential treatments from
the laboratory to Parkinson's patients, and have worked with Katie and the
entire executive team to develop a compell
|SOURCE Michael J. Fox Foundation|
Copyright©2007 PR Newswire.
All rights reserved